{
  "paper_metadata": {
    "pmid": "26338094",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses variants in the TTR gene, specifically the Val30Met mutation, and provides details on patient demographics, penetrance data, and functional studies."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.149G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 29,
        "demographics": "All patients were white, 69% male, mean age 56 years.",
        "phenotype": "Familial amyloid polyneuropathy (FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 29,
        "affected_count": 22,
        "unaffected_count": 7,
        "uncertain_count": null,
        "penetrance_percentage": 75.86,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 55,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 41,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 58,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 53,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P10",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P11",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P12",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P13",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P14",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P15",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P16",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P17",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P18",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P19",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P20",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P21",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P22",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P23",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P24",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P25",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P26",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P27",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P28",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        },
        {
          "individual_id": "P29",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "FAP with neuropathy",
          "evidence_sentence": "The majority of patients (76%) had the Val30Met TTR mutation."
        }
      ],
      "functional_data": {
        "summary": "Patisiran led to significant knockdown of TTR protein levels.",
        "assays": [
          "ELISA",
          "mass spectrometry"
        ]
      },
      "segregation_data": "The Val30Met mutation is known to segregate with disease in families.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study included a diverse cohort of patients with FAP.",
      "key_quotes": [
        "The most common mutations associated with familial amyloid polyneuropathy (FAP) and ATTR-associated cardiomyopathy, respectively, are Val30Met.",
        "The majority of patients (76%) had the Val30Met TTR mutation."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Baseline demographics and disease characteristics (intent-to-treat population)",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}